TY - JOUR
T1 - An overview of recent treatment options for primary sclerosing cholangitis
AU - Mousavere, Ioanna
AU - Kalampokis, Georgios
AU - Fousekis, Fotios
AU - Karayiannis, Peter
AU - Baltayiannis, Gerasimos
AU - Christodoulou, Dimitrios
N1 - Publisher Copyright:
© 2023 Hellenic Society of Gastroenterology.
PY - 2023/11/23
Y1 - 2023/11/23
N2 - Primary sclerosing cholangitis (PSC) is a chronic hepatic dysfunction characterized by inflammatory and tissue-degenerative strictures of the biliary tree, leading to cirrhosis and cholangiocarcinoma. The pathophysiological mechanisms involve immune-mediated responses. Numerous treatment modalities targeting the inflammatory aspects have been suggested, but a consensus on the best treatment option is lacking. This study aims to review the most up-to-date treatment options for PSC.
AB - Primary sclerosing cholangitis (PSC) is a chronic hepatic dysfunction characterized by inflammatory and tissue-degenerative strictures of the biliary tree, leading to cirrhosis and cholangiocarcinoma. The pathophysiological mechanisms involve immune-mediated responses. Numerous treatment modalities targeting the inflammatory aspects have been suggested, but a consensus on the best treatment option is lacking. This study aims to review the most up-to-date treatment options for PSC.
KW - management
KW - Primary sclerosing cholangitis
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85177646537&partnerID=8YFLogxK
U2 - 10.20524/aog.2023.0834
DO - 10.20524/aog.2023.0834
M3 - Review article
AN - SCOPUS:85177646537
SN - 1108-7471
VL - 36
SP - 589
JO - Annals of Gastroenterology
JF - Annals of Gastroenterology
IS - 6
ER -